Advanced Biomedical Technologies Inc (ABMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2022 | 07-2022 | 04-2022 | 10-2021 | 07-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 6 | 29 | 37 | 7 |
| Receivables | N/A | 21 | 24 | 76 | 47 |
| Inventories | N/A | 240 | 216 | 189 | 189 |
| TOTAL | $N/A | $267 | $269 | $302 | $243 |
| Non-Current Assets | |||||
| PPE Net | N/A | 117 | 125 | 140 | 144 |
| Other Non-Current Assets | 0 | 0 | 0 | 7 | 10 |
| TOTAL | $N/A | $117 | $125 | $147 | $154 |
| Total Assets | $N/A | $384 | $393 | $449 | $397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 8,700 | 8,674 | 8,826 | 8,568 |
| TOTAL | $N/A | $8,700 | $8,674 | $8,833 | $8,579 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $8,700 | $8,674 | $8,833 | $8,579 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 70,905 | 70,605 | 70,605 | 70,605 | 70,225 |
| Common Shares | N/A | 1 | 1 | 1 | 1 |
| Retained earnings | N/A | -11,308 | -11,118 | -10,986 | -10,816 |
| Other shareholders' equity | 0 | 108 | -43 | -270 | -203 |
| TOTAL | $N/A | $-8,316 | $-8,281 | $-8,384 | $-8,182 |
| Total Liabilities And Equity | $0 | $384 | $393 | $449 | $397 |